Moderna Testing Potential Monkeypox Vaccines

Reuters2022-05-25

(Reuters) - Moderna Inc is testing potential vaccines against monkeypox in pre-clinical trials as the disease spreads in the United States and Europe.

The World Health Organization said on Tuesday there have been 131 confirmed monkeypox cases and 106 further suspected cases since the first was reported on May 7 outside the countries where it usually spreads. read more

Moderna did not immediately respond to a request for more details on the monkeypox vaccines.

The U.S. Centers for Disease Control and Prevention said the government was in the process of releasing doses of a smallpox vaccine Jynneos, made by Bavarian Nordic A/S (BAVA.CO), for use in monkeypox cases.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

  • Ziger1
    2022-05-26
    Ziger1
    😶
  • DragonKC
    2022-05-25
    DragonKC
    Market tricks want to boost moderna stock up. If monkeypox is like covid. Can't imagine what the world will be. Who's going to take monkeypox vaccine.???? 
  • LWKJKK
    2022-05-25
    LWKJKK
    Load more now else it will increase to over $200+ again! 
  • JcJc
    2022-05-25
    JcJc
    [Surprised] 
  • Kwgan
    2022-05-25
    Kwgan
    K
  • Joyus
    2022-05-25
    Joyus
    👍
Leave a comment
9